PATENT CLAIM ANALYSIS

Application Number: 15748519
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "059000"]

Abstract:
The present embodiments relate to the use of dextran sulfate formulated for systemic administration for treatment, inhibition or prevention of cardiac fibrosis in a subject.

Claim (Index 34):
The method according to  claim 33 , wherein systemically administering comprises systemically administering said dextran sulfate, or said pharmaceutically acceptable salt thereof, at 3 times a week for 3 consecutive weeks to said subject.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 86.0
- Lexical Diversity: 1.08
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15316789', '13810425', '14890636', '14099518', '12685005']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7660248668230155
- 35 USC 102 Novelty (BERT): 0.4896972873284862
- Combined Prediction Score: 0.7383921088735627
- Mean Citation Score: 204.53058600000003
- Max Citation Score: 236.29549
- Similarity Product: 191.290602515564

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test